ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 135 filers reported holding ANTARES PHARMA INC in Q3 2019. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $26,000 | +13.0% | 7,850 | -30.2% | 0.02% | +130.0% |
Q2 2015 | $23,000 | -34.3% | 11,250 | -18.2% | 0.01% | -41.2% |
Q4 2014 | $35,000 | +40.0% | 13,750 | 0.0% | 0.02% | +54.5% |
Q3 2014 | $25,000 | -32.4% | 13,750 | 0.0% | 0.01% | -31.2% |
Q2 2014 | $37,000 | -33.9% | 13,750 | 0.0% | 0.02% | -44.8% |
Q3 2013 | $56,000 | +14.3% | 13,750 | 0.0% | 0.03% | -12.1% |
Q1 2013 | $49,000 | -14.0% | 13,750 | -8.3% | 0.03% | -15.4% |
Q4 2012 | $57,000 | -16.2% | 15,000 | -3.2% | 0.04% | -11.4% |
Q3 2012 | $68,000 | – | 15,500 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |